KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Revenue for 14 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 101.54% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 66.63% year-over-year, with the annual reading at $9.7 million for FY2025, 146.73% up from the prior year.
  • Revenue for Q4 2025 was $7.9 million at Precigen, up from $41000.0 in the prior quarter.
  • The five-year high for Revenue was $24.5 million in Q1 2021, with the low at -$10.1 million in Q4 2021.
  • Average Revenue over 5 years is $2.9 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Revenue crashed 152.12% in 2021, then soared 14240.0% in 2024.
  • Over 5 years, Revenue stood at -$10.1 million in 2021, then surged by 103.3% to $333000.0 in 2022, then soared by 1550.15% to $5.5 million in 2023, then dropped by 28.97% to $3.9 million in 2024, then soared by 101.54% to $7.9 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $7.9 million, $41000.0, and $23000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.